BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7215100)

  • 1. [Treatment of Parkinson disease by bromocriptine in the black African].
    Ndiaye IP; Jacquin-Cotton L; Martini L
    Dakar Med; 1980; 25(2):131-5. PubMed ID: 7215100
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bromocriptine in the treatment of Parkinson's disease].
    Sepcić J; Ledić P
    Neurologija; 1982; 30(1-4):75-81. PubMed ID: 6765062
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of bromocriptine in Parkinson diseases in low doses at a slow rate. 40 patients].
    Liaño H; López-Lozano JJ; Ramírez A; Rabes C; Pascual ML
    Arch Neurobiol (Madr); 1984; 47(3):143-50. PubMed ID: 6508478
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bromocriptine in Parkinson's disease. Personal experience].
    Chacón JR; Piqueras L; Pery JM
    Arch Neurobiol (Madr); 1982; 45(5):371-80. PubMed ID: 7165448
    [No Abstract]   [Full Text] [Related]  

  • 5. Levodopa compared with bromocriptine in the treatment of Parkinson's disease.
    Godwin-Austen RB
    Adv Biochem Psychopharmacol; 1980; 23():261-5. PubMed ID: 7395616
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparative study of bromocriptine and levodopa in Parkinson's disease.
    Duvoisin RC; Mendoza MM; Yahr MD
    Adv Biochem Psychopharmacol; 1980; 23():271-5. PubMed ID: 7395618
    [No Abstract]   [Full Text] [Related]  

  • 7. [Parlodel: a new therapeutic possibility in the management of Parkinson disease].
    Glaub T; Berecz G; Pintér N; Diószeghy P; Virga A; Mechler F
    Orv Hetil; 1988 Feb; 129(8):399-402. PubMed ID: 3279375
    [No Abstract]   [Full Text] [Related]  

  • 8. [Long-term results of treatment of Parkinson's disease with bromocriptine and domperidone (author's transl)].
    Agid Y; Quinn N; Lhermitte F
    Rev Neurol (Paris); 1981; 137(1):49-51. PubMed ID: 7232966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of bromocriptine in the treatment of Parkinson's disease.
    Stern GM; Lees AJ; Shaw KM; Lander CM
    Adv Biochem Psychopharmacol; 1980; 23():267-70. PubMed ID: 7395617
    [No Abstract]   [Full Text] [Related]  

  • 10. [Improved therapeutic response to L-dopa in Parkinson's disease, when combined with bromocriptine (author's transl)].
    Ulm G
    Nervenarzt; 1981 Feb; 52(2):116-20. PubMed ID: 7219619
    [No Abstract]   [Full Text] [Related]  

  • 11. Cognitive performances in parkinsonians before and after bromocriptine therapy.
    Piccirilli M; Piccinin GL; D'Alessandro P; Finali G; Piccolini C; Scarcella MG; Testa A
    Acta Neurol (Napoli); 1986 Jun; 8(3):167-72. PubMed ID: 3739763
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease.
    Mizuno Y; Yanagisawa N; Kuno S; Yamamoto M; Hasegawa K; Origasa H; Kowa H;
    Mov Disord; 2003 Oct; 18(10):1149-56. PubMed ID: 14534919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Psychosis due to the interaction of erythromycin and bromocriptine in Parkinson disease].
    Alegre M; Noé E; Martínez Lage JM
    Neurologia; 1997 Nov; 12(9):429. PubMed ID: 9471184
    [No Abstract]   [Full Text] [Related]  

  • 14. Bromocriptine in Parkinson's disease: report on 106 patients treated for up to 5 years.
    Lieberman AN; Kupersmith M; Neophytides A; Gopinathan G; Casson I; Durso R; Foo SH; Khayali M; Tartaro T; Goldstein M
    Adv Biochem Psychopharmacol; 1980; 23():245-53. PubMed ID: 7395614
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bromocriptine].
    Raphael V
    Soins Gynecol Obstet Pueric Pediatr; 1989 Nov; (102):I-II. PubMed ID: 2617395
    [No Abstract]   [Full Text] [Related]  

  • 16. [The value of bromocriptine in the therapy of Parkinson disease].
    Castro-Caldas A
    Acta Med Port; 1981; 3(3):239-43. PubMed ID: 7325011
    [No Abstract]   [Full Text] [Related]  

  • 17. The Parkinson-Control study: a 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease.
    Castro-Caldas A; Delwaide P; Jost W; Merello M; Williams A; Lamberti P; Aguilar M; Del Signore S; Cesaro P;
    Mov Disord; 2006 Apr; 21(4):500-9. PubMed ID: 16267842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of L-dopa induced dyskinesia and of on-off phenomenon by bromocriptine.
    Ludin HP
    Acta Neurol Belg; 1980; 80(1):5-9. PubMed ID: 7361542
    [No Abstract]   [Full Text] [Related]  

  • 19. Low dose bromocriptine ameliorates hallucinations in a demented parkinsonian patient.
    Sandyk R
    J Clin Psychopharmacol; 1987 Apr; 7(2):114-5. PubMed ID: 3584516
    [No Abstract]   [Full Text] [Related]  

  • 20. [Parlodel in early combination with levodopa in the treatment of Parkinson disease. Comparison of 2 dosage forms].
    Goulley F; Wolmark Y; Bourdeix I; Chaumet-Riffaud PD
    Therapie; 1993; 48(3):233-8. PubMed ID: 7908147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.